461 related articles for article (PubMed ID: 22054617)
1. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
[TBL] [Abstract][Full Text] [Related]
4. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis.
Chu CK; Farnell MB; Nguyen JH; Stauffer JA; Kooby DA; Sclabas GM; Sarmiento JM
J Am Coll Surg; 2010 Sep; 211(3):316-24. PubMed ID: 20800187
[TBL] [Abstract][Full Text] [Related]
5. Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer.
Nakao A; Kanzaki A; Fujii T; Kodera Y; Yamada S; Sugimoto H; Nomoto S; Nakamura S; Morita S; Takeda S
Ann Surg; 2012 Jan; 255(1):103-8. PubMed ID: 22156923
[TBL] [Abstract][Full Text] [Related]
6. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
[TBL] [Abstract][Full Text] [Related]
7. Adverse tumor biology associated with mesenterico-portal vein resection influences survival in patients with pancreatic ductal adenocarcinoma.
Wang F; Gill AJ; Neale M; Puttaswamy V; Gananadha S; Pavlakis N; Clarke S; Hugh TJ; Samra JS
Ann Surg Oncol; 2014 Jun; 21(6):1937-47. PubMed ID: 24558067
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma of the pancreas with portal vein involvement--our experience with a modified technique of resection.
Jain S; Sacchi M; Vrachnos P; Lygidakis NJ
Hepatogastroenterology; 2005; 52(65):1596-600. PubMed ID: 16201124
[TBL] [Abstract][Full Text] [Related]
9. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma.
Aramaki M; Matsumoto T; Etoh T; Ishio T; Himeno Y; Sasaki A; Yada K; Kawano K; Kitano S
Hepatogastroenterology; 2003; 50(49):263-6. PubMed ID: 12630036
[TBL] [Abstract][Full Text] [Related]
11. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.
Kaneoka Y; Yamaguchi A; Isogai M
Surgery; 2009 Apr; 145(4):417-25. PubMed ID: 19303991
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
13. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
14. Impact of portal vein invasion and resection length in pancreatoduodenectomy on the survival rate of pancreatic head cancer.
Kurihara C; Yoshimi F; Sasaki K; Nakao K; lijima T; Kawasaki H; Nagai H
Hepatogastroenterology; 2013 Oct; 60(127):1759-65. PubMed ID: 24634947
[TBL] [Abstract][Full Text] [Related]
15. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update.
van Geenen RC; van Gulik TM; Offerhaus GJ; de Wit LT; Busch OR; Obertop H; Gouma DJ
Eur J Surg Oncol; 2001 Sep; 27(6):549-57. PubMed ID: 11520088
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
17. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
[TBL] [Abstract][Full Text] [Related]
18. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.
van Geenen RC; ten Kate FJ; de Wit LT; van Gulik TM; Obertop H; Gouma DJ
Surgery; 2001 Feb; 129(2):158-63. PubMed ID: 11174708
[TBL] [Abstract][Full Text] [Related]
19. Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancer.
Shimoda M; Mori S; Kita J; Sawada T; Kubota K
Hepatogastroenterology; 2013; 60(128):2094-8. PubMed ID: 24719953
[TBL] [Abstract][Full Text] [Related]
20. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
